The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Levin O.S.

Russian Medical Academy of Continuous Professional Education

To study the effectiveness and impact on the quality of life of patients with subclinical and clinically pronounced anxiety disorder of a mobile application in combination with Adaptol therapy

Authors:

Levin O.S.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2024;124(7): 98‑105

DOI: 10.17116/jnevro202412407198

Read: 1900 times

Download PDF (RU)
Contact the author
Table of contents

TO STUDY THE EFFECTIVENESS AND IMPACT ON THE QUALITY OF LIFE OF PATIENTS WITH SUBCLINICAL AND CLINICALLY PRONOUNCED ANXIETY DISORDER OF A MOBILE APPLICATION IN COMBINATION WITH ADAPTOL THERAPY
TO STUDY THE EFFECTIVENESS AND IMPACT ON THE QUALITY OF LIFE OF PATIENTS WITH SUBCLINICAL AND CLINICALLY PRONOUNCED ANXIETY DISORDER OF A MOBILE APPLICATION IN COMBINATION WITH ADAPTOL THERAPY

To cite this article:

Levin OS. To study the effectiveness and impact on the quality of life of patients with subclinical and clinically pronounced anxiety disorder of a mobile application in combination with Adaptol therapy. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;124(7):98‑105. (In Russ.)
https://doi.org/10.17116/jnevro202412407198

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)
 
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Evaluation of blepharoplasty outcomes using psychometric scales. Plastic Surgery and Aesthetic Medi­cine. 2024;(4-2):72-79
The rela­tionship between neighborhood infrastructure and stress levels in students. Russian Journal of Preventive Medi­cine. 2024;(11):70-76
App-based first aid learning: what applications do we have now?. Russian Journal of Anesthesiology and Reanimatology. 2024;(6):89-103
Effi­ciency of complex medi­cal reha­bilitation after pulmonary enda­rterectomy. Russian Journal of Cardiology and Cardiovascular Surgery. 2024;(6):629-636
Simu­ltaneous auto­plastic repair and diastasis recti correction for linea alba hernias. Russian Journal of Evidence-Based Gastroenterology. 2024;(4):34-39
Predictors of Enga­gement and Active participation of Patients with Unco­ntrolled Hype­rtension in the Tele­health Surveillance Program. Russian Journal of Preventive Medi­cine. 2024;(12):37-43
Effe­ctiveness of the second stage program of medi­cal reha­bilitation of patients with ischemic heart disease. Russian Journal of Preventive Medi­cine. 2024;(12):75-80
Asse­ssment of risk of deve­loping fractures and sarcopenia and quality of life of patients with chro­nic kidney disease at the outpatient stage. Russian Journal of Preventive Medi­cine. 2024;(12):88-91
Reco­mmendations for the reha­bilitation of patients with chro­nic kidney disease requiring hemo­dialysis (literature review). Problems of Balneology, Physiotherapy and Exercise Therapy. 2024;(6):62-73
Atopic dermatitis and skin toxic reactions: comparative characteristics, psychosomatic aspe­cts and patient mana­gement tactics. Russian Journal of Clinical Dermatology and Vene­reology. 2024;(6):744-752
Abstract:

OBJECTIVE

To study the effectiveness and the quality of life impact of the mobile application Zdorovye.ru in people with subclinical and clinical anxiety disorder (AD).

MATERIAL AND METHODS

200 patients with more than 7 points on the Hospital Anxiety and Depression Scale (HADS) were included. Participants were randomized into two groups: experimental one (EG, n=133) — to receive standard treatment with temgicoluril (Adaptol), 500 mg (Olainfarm JSC, Latvia) and the Zdorovye.ru application; control group (CG, n=52) — standard treatment with temgicoluril (Adaptol).

RESULTS

There were a significant decrease in the HADS-A score, PSS-10 score and an increase in the visual analog scale EQ-5D score in both groups after 3 months of treatment (p<0.001). Clinical improvement was noticeable after 1.5 months in EG group: a decrease in HADS-A scores (p=0.001) and in tension and stress on PSS-10 subscales (p<0.001) were noted. This effect was not observed in the CG. After 3 months, all participants noted an improvement in quality of life (p<0.001), without a statistically significant difference between groups (p=0.233). The application left a positive impression on users and doctors — most respondents rated it as useful and clear.

CONCLUSION

Taking temgicoluril (Adaptol) for 3 months led to symptoms decrease and the quality of life and well-being improvement in patients with AD. Using the mobile application Zdorovye.ru in conjunction with drug therapy made it possible to achieve a clinical effect earlier, in 1.5 months.

Keywords:

anxiety disorder
mobile application
temgicoluril
Adaptol
quality of life
stress

Authors:

Levin O.S.

Russian Medical Academy of Continuous Professional Education

Received:

30.05.2024

Accepted:

04.06.2024

Close metadata

References:

  1. Bandelow B, Michaelis S. Epidemiology of anxiety disorders in the 21st century. Dial Clin Neurosci. 2015;17(3):327-335.  https://doi.org/10.31887/dcns.2015.17.3/bbandelow
  2. World Health Organization. Mental Health and COVID-19: Early evidence of the pandemic’s impact: Scientific brief, 2 March 2022. 2022. Accessed: 27.05.2024. https://www.who.int/publications/i/item/WHO-2019-nCoV-Sci_Brief-Mental_health-2022.1
  3. Klinicheskie rekomendacii Ministerstva zdravooxraneniya Rossijskoj Federacii. Trevozhno-fobicheskie rasstrojstva u vzrosly’x. 2021. Accessed: 27.05.24. (In Russ.). https://cr.minzdrav.gov.ru/recomend/455_2
  4. Stein DJ, Lim CCW, Roest A.M, et al. and WHO World Mental Health Survey Collaborators. The cross-national epidemiology of social anxiety disorder: Data from the World Mental Health Survey Initiative. BMC Med. 2017;15(1):143.  https://doi.org/10.1186/s12916-017-0889-2
  5. Kirpichenka AA, Baryshau AN. Anxiety and depression screening in general medical practice: the current state of the matter. Vestnik of Vitebsk State Medical University. 2020;19(5):8-16. (In Russ.). https://doi.org/10.22263/2312-4156.2020.5.8
  6. Drapkina OM, Kontsevaya AV, Kalinina AM, et al. Prevention of chronic non-communicable diseases in the Russian Federation. National guidelines. Cardiovascular Therapy and Prevention. 2022;21(4):3235. (In Russ.). https://doi.org/10.15829/1728-8800-2022-3235
  7. Shishkova VN. Anxiety in subjects with cardiovascular disease: Current diagnostic strategies and therapeutic options. A review. Terapevticheskii Arkhiv (Ter. Arkh.). 2023;95(8):710-715. (In Russ.). https://doi.org/10.26442/00403660.2023.08.202207
  8. Smirnova MD, Svirida ON, Fofanova TV, et al. Subclinical depression and anxiety as an additional risk factor for cardiovascular events in low- and moderate-risk patients: data from 10-year follow-up. Cardiovascular Therapy and Prevention. 2021;20(4):2762. (In Russ.). https://doi.org/10.15829/1728-8800-2021-2762
  9. Volpato E, Toniolo S, Pagnini F, Banfi P. The relationship between anxiety, depression and treatment adherence in chronic obstructive pulmonary disease: a systematic review. Int J Chron Obstr Pulm Dis. 2021;16:2001-2021. https://doi.org/10.2147/copd.s313841
  10. Willgoss TG, Yohannes AM. Anxiety disorders in patients with COPD: a systematic review. Resp Care. 2013;58(5):858-866.  https://doi.org/10.4187/respcare.01862
  11. Elbinoune I, Amine B, Shyen S, et al. Chronic neck pain and anxiety-depression: prevalence and associated risk factors. Pan African Med J. 2016;24:89.  https://doi.org/10.11604/pamj.2016.24.89.8831
  12. Bisby MA, Karin E, Scott AJ, et al. Examining the psychometric properties of brief screening measures of depression and anxiety in chronic pain: The Patient Health Questionnaire 2-item and Generalized Anxiety Disorder 2-item. Pain Pract. 2022;22(4):478-486.  https://doi.org/10.1111/papr.13107
  13. Lerman SF, Rudich Z, Brill S, et al. Longitudinal associations between depression, anxiety, pain, and pain-related disability in chronic pain patients. Psychosom Med. 2015;77(3):333-341.  https://doi.org/10.1097/psy.0000000000000158
  14. Shcherbakova IV, Krylatykh VYu, Bardenshteyn LM. The psycho-pharmacotherapy of anxiety disorders: problem actual view. Rossiiskii Meditsinskii Zhurnal. 2017;23(2):107-112 (In Russ.). https://doi.org/10.18821/0869-2106-2017-23-2-107-112
  15. Kryzhanovskiy SM, Samushia MA, Iosava IK, Berestovoy MA. Adaptol effectiveness in the therapy of anxiety-depressive syndrome in patients with somatic pathologies: a systematic analysis. Kremlin Medicine. 2023;1:43-50. (In Russ.). https://doi.org/10.48612/cgma/ppb5-8g43-ut1g
  16. Levin OS, Rachin SA. Effectiveness of Adaptol in the treatment of emotional disorders in patients with physical illnesses. Pharmacology & Pharmacotherapy. 2022;(5):68-72. (In Russ.). https://doi.org/10.46393/27132129_2022_5_68
  17. Bunova AS, Shikova DV. Mobile applications for the control of anxiety and depression symptoms: search and quality evaluation. Russian Journal of Preventive Medicine. 2023;26(10):27-35. (In Russ.). https://doi.org/10.17116/profmed20232610127
  18. Zamyatin KA, Nozdrachev DI, Solovieva MN. Mobile applications for anxiety and stress reduction: potential for preventing noncommunicable diseases. Russian Journal of Cardiology. 2021;26(9):4681. (In Russ.). https://doi.org/10.15829/1560-4071-2021-4681
  19. Morozova MA, Potanin SS, Beniashvili AG, et al. Validation of the Hospital Anxiety and Depression Scale Russian-language version in the general population. Russian Journal of Preventive Medicine. 2023;26(4):7-14. (In Russ.). https://doi.org/10.17116/profmed2023260417
  20. Ababkov VA, Barisnikov K, Vorontzova-Wenger OV, et al. of the Russian version of the questionnaire «Scale of perceived stress-10». Vestnik of Saint-Petersburg University. Series 16. Psychology. Education. 2016;2:6-15. (In Russ.). https://doi.org/10.21638/11701/spbu16.2016.202
  21. Akulova AI, Gaydukova IZ, Rebrov AP. Validation of the EQ-5D-5L version In Russia. NauchnoPrakticheskaya Revmatologiya = Rheumatology Science and Practice. 2018;56(3):351-355. (In Russ.). https://doi.org/10.14412/1995-4484-2018-351-355
  22. Lukina YuV, Kutishenko NP, Martsevich SYu, Drapkina OM. The Questionnaire Survey Method in Medicine on the Example of Treatment Adherence Scales. Rational Pharmacotherapy in Cardiology. 2020;17(4):576-583. (In Russ.). https://doi.org/10.20996/1819-6446-2021-08-02
  23. Kotova OV, Belyaev AA, Akarachkova ES. State-of-the-art diagnostic and treatment modalities for anxiety and depression. Russian Medical Inquiry. 2021;5(10):648-653 (In Russ.). https://doi.org/10.32364/2587-6821-2021-5-10-648-653
  24. Drissi N, Ouhbia S, Idrissib MAJ, Ghogho M. An analysis on self-management and treatment-related functionality and characteristics of highly rated anxiety apps. Int J Med Inf. 2020;141:104243. https://doi.org/10.1016/j.ijmedinf.2020.104243
  25. Boettcher J, Magnusson K, Marklund A, et al. Adding a smartphone app to Internet-based self-help for social anxiety: a randomized controlled trial. Comput Hum Behav. 2018;87: 34-39.  https://doi.org/10.1016/j.chb.2018.04.052
  26. Domhardt M, Geßlein H, Rezori RE, Baumeister H. Internet- and mobile-based interventions for anxiety disorders: a meta-analytic review of intervention components. Depression Anxiety. 2019;36(3):213-224.  https://doi.org/10.1002/da.22860
  27. Graham AK, Greene CJ, Kwasny MJ, et al. Coached mobile app platform for the treatment of depression and anxiety among primary care patients: a randomized clinical trial. JAMA Psychiatry. 2020;77(9):906-914.  https://doi.org/10.1001/jamapsychiatry.2020.1011
  28. Proudfoot J, Clarke J, Birch MR, et al. Impact of a mobile phone and web program on symptom and functional outcomes for people with mild-to-moderate depression, anxiety and stress: a randomised controlled trial. BMC Psychiatry. 2013;13:312.  https://doi.org/10.1186/1471-244x-13-312
  29. Rozanov VA, Samerkhanova KM. Mobile applications for mental health self-management: a review of customers’ opinions. Russian Journal of Telemedicine and E-Health. 2022;8(2)7-20. (In Russ.). https://doi.org/10.29188/2712-9217-2022-8-2-7-20
  30. Linardon J, Cuijpers P, Carlbring P, et al. The efficacy of app-supported smartphone interventions for mental health problems: a meta-analysis of randomized controlled trials. World Psychiatry. 2019;18(3):325-336.  https://doi.org/10.1002/wps.20673
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.